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OBJECTIVES: The ability of the Timed Up and Go test to predict sarcopenia has not been evaluated previously.
The objective of this study was to evaluate the accuracy of the Timed Up and Go test for predicting sarcopenia
in elderly hospitalized patients.
METHODS: This cross-sectional study analyzed 68 elderly patients (X60 years of age) in a private hospital in the
city of Salvador-BA, Brazil, between the 1st and 5th day of hospitalization. The predictive variable was the
Timed Up and Go test score, and the outcome of interest was the presence of sarcopenia (reduced muscle mass
associated with a reduction in handgrip strength and/or weak physical performance in a 6-m gait-speed test).
After the descriptive data analyses, the sensitivity, specificity and accuracy of a test using the predictive variable
to predict the presence of sarcopenia were calculated.
RESULTS: In total, 68 elderly individuals, with a mean age 70.4±7.7 years, were evaluated. The subjects had a
Charlson Comorbidity Index score of 5.35±1.97. Most (64.7%) of the subjects had a clinical admission profile;
the main reasons for hospitalization were cardiovascular disorders (22.1%), pneumonia (19.1%) and abdominal
disorders (10.2%). The frequency of sarcopenia in the sample was 22.1%, and the mean length of time spent
performing the Timed Up and Go test was 10.02±5.38 s. A time longer than or equal to a cutoff of 10.85 s on
the Timed Up and Go test predicted sarcopenia with a sensitivity of 67% and a specificity of 88.7%. The accuracy
of this cutoff for the Timed Up and Go test was good (0.80; IC=0.66-0.94; p=0.002).
CONCLUSION: The Timed Up and Go test was shown to be a predictor of sarcopenia in elderly hospitalized
patients.
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The performance of daily living activities, as evaluated
with specific physical tests, is associated with clinically
relevant outcomes, such as mortality and quality of life (1).
It might be important for elderly hospitalized patients to
undergo physical tests to evaluate skeletal muscle function,
which could be severely compromised by aging and
comorbidities (1).
Aging is responsible for changes in peripheral muscle
mass and strength, particularly after 50 years of age, when
muscle mass declines by 1 to 2% per year, and muscle
strength declines by 1.5 to 5% per year (2). Longitudinal
studies have demonstrated that reductions in muscle
strength predict mortality over a period of years to a greater
extent than do changes in skeletal muscle mass (3,4).
Additionally, studies have noted that physical tests might
be useful for evaluating reductions in mobility in elderly
individuals; these reductions might be related to decreased
muscle mass and strength, which is known as sarcopenia (5).
In addition to muscle-mass and muscle-strength parameters,
gait speed has been evaluated to assess physical perfor-
mance; in particular, the Timed Up and Go (TUG) is a simpleDOI: 10.6061/clinics/2015(05)11
Copyright & 2015 CLINICS – This is an Open Access article distributed under the
terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial
use, distribution, and reproduction in any medium, provided the original work is
properly cited.
No potential conflict of interest was reported.
369
CLINICAL SCIENCE
test that could be used even in a limited-resource environ-
ment to assess physical performance (5). Additionally,
elderly patients readily perform the TUG test, and TUG-test
scores are well correlated with the risk of falling in this
patient group (6,7). In a recent study that evaluated elderly
patients in a primary care setting, the cutoff TUG-test score
for predicting falls was a value greater than 12.47 s (8). To
our knowledge, the ability of the TUG test to predict
sarcopenia has not been evaluated.
The goal of this study was to evaluate the accuracy of the
TUG test in predicting sarcopenia in a sample of elderly
inpatients.
’ METHODS
This work was a cross-sectional study conducted from
August 2013 to January 2014 in a hospital that assists
patients from public and private healthcare systems in Brazil.
The inclusion criteria for this study were age X60 years,
body mass index (BMI) o30 kg/m2, enrollment between
the 1st and 5th day of hospitalization, self-report of walking
independently and without external help prior to hospitali-
zation, a physician’s permission to walk without assistance
after hospitalization, and no use of vasoactive and/or
inotropic drugs. The exclusion criteria were peripheral
oxygen saturation (SpO2) lower than 90% during an
evaluation, an increase in heart rate (HR) of more than 30%
of the baseline value (before the test began) and dyspnea or
discomfort during the performance of the tests. This project
was approved by the ethics committee of the Bahia School of
Medicine and Public Health (protocol number 336.469), and
all of the study participants signed informed consent forms
and were provided information regarding participation in
the study.
Measurements
First, anthropometric measurements were taken, and
handgrip strength and physical performance were measured
using the gait-speed and TUG tests. Additionally, we
assessed self-reports of falls during the previous year and
of cognitive function. The data were obtained from the
patient records including the diagnoses at medical admis-
sion, the admission profile (surgical or clinical), the Charlson
Comorbidity Index score and the length of stay at the time of
the data collection.
The diagnostic criteria for sarcopenia were a reduction in
skeletal muscle mass (SMM), with reduced handgrip strength
and/or poor physical performance in a 6-m gait-speed test. The
SMM was obtained using the Lee anthropometric equation,
which yields results that are highly correlated with the SMM
calculated with magnetic resonance data (9) and dual-energy
X-ray absorptiometry (DXA, previously DEXA) data (10,11).
SMM was calculated as a function of weight and height as
follows: (height [m]  0.244  bodymass)+ (7.8  height)+
(6.6  sex) – (0.098  age)+ (ethnicity – 3.3). The SMM index
was then calculated by dividing an individual’s SMM (kg) by his
or her height squared (m2). The criteria used to identify a
reduction in SMM were values p6.37 kg/m2 for women and
p8.90 kg/m2 for men, which are equivalent to 20% of lowest
percentile distribution reported by Alexandre et al. (12).
To evaluate handgrip strength, each subject was seated in a
chair, with the elbows at 90°, and was asked to exert
maximum force on a Saehan dynamometer (SAEHAN
CORPORATION, Yangdeok-Dong, Masan, South Korea) (13).
This measurement was performed three times with a rest
interval of one minute between measurements; the greatest
measurement was reported. The criteria for muscle weakness
indicative of sarcopenia were values lower than 20 kg in
women and lower than 30 kg in men (14).
The 6-m walking test was conducted to assess an
individual’s physical performance. To perform this test, each
subject was asked to walk 10 m on a flat, straight course at
the fastest possible speed, and the time required to walk the
central 6 m was measured. The highest speed among three
measurements was used in the analyses, with values lower
than or equal to 0.8 m/s being considered weak physical
performance indicative of sarcopenia (15). To measure
physical performance using the TUG test, each individual
was asked to stand up from a seated position, walk 3 m and
then return to a seated position on the same chair, while a
previously trained physical therapist measured the time (s)
required to perform this task (16).
The body mass index (BMI) of each subject was obtained
by dividing his or her body weight (kg) by his or her squared
height (m2). The World Health Organization criteria were
used to classify the subjects as low-weight (BMIo18.5),
eutrophic (18.5oBMIp24.99), overweight (25pBMIp29.99)
or obese (BMIX30.00) (17). Cognitive function was evaluated
using the mini-mental state examination (MMSE) (18), which
quantifies various cognitive abilities, such as orientation,
attention, calculation, visuo-constructive ability, language
and evocation, with a score that ranges from 0 to 30 points.
The Charlson Comorbidity Index was used to evaluate the
presence of comorbidities, and the data were collected within
the first 24 hours (19).
Statistical analysis
The numerical data were described by the means and
standard deviations, and the categorical data were described
by the proportions and confidence intervals. The accuracy
was evaluated using receiver operating characteristic (ROC)
curves obtained from the sensitivity and specificity analyses;
the TUG test measured the physical performance as the
predictive variable and the presence of sarcopenia as the
outcome variable. Student’s t-test was used for the inter-
group comparisons of the numerical variables (the age,
muscle mass index, mental function, length of hospital stay
at the time of the data collection, Charlson Comorbidity
Index score and physical performance) using a cut-off of
X10.85 s on the TUG test for the prediction of sarcopenia.
These analyses were performed using the SPSS statistical
software, version 14.0.
’ RESULTS
In total, 68 elderly hospitalized individuals (58.8% males)
were evaluated, and 22.1% of these patients had sarcopenia.
The mean age of the study subjects was 70.4±7.7 years, and
the mean BMI was 25.7±3.3 kg/m2. Most (64.7%) of the
study subjects had a clinical admission profile. The major
reasons for hospitalization were cardiovascular disorders
(22.1%), pneumonia (19.1%), abdominal surgery (19.1%) and
abdominal disorders (10.2%). The mean duration of hospi-
talization at the time of the data collection was 2.76±1.71
days, and the subjects’ mean Charlson Comorbidity Index
score was 5.35±1.97. Regarding the self-reports of falls in the
previous year, 30.9% of the subjects reported having had
at least one fall in the previous year (Table 1). The accuracy
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of TUG was considered moderate (0.80; IC = 0.66–0.94;
p-value = 0.001) for predicting sarcopenia in the sample
studied. After the analysis of the ROC curve, we observed
that TUG presented a sensitivity of 66.7% and specificity of
88.7% for the prediction of sarcopenia (Table 2). The
sarcopenia predictor cut-off point was a TUGX10.85
seconds, found in the point of greatest accuracy in the
ROC curve (Figure 1). In the intergroup comparison, the
elderly with a physical performance predictive of sarcopenia
(TUGX10.85 seconds) had worse cognitive function, were
older and presented higher scores of the Charlson comor-
bidity index and a lower quantity of skeletal muscle mass.
There were no significant differences in the comparison
between the mean duration of hospitalization (Table 3).
’ DISCUSSION
This study found that the TUG test predicted sarcopenia in
elderly hospitalized patients with good accuracy. This
finding suggests that this test might be a useful in the
evaluation of at risk-patients with similar profiles in the
hospital environment. This study evaluated, for the first
time, the ability of the TUG test of physical performance to
predict the presence of sarcopenia.
The cut-off point that predicted sarcopenia in this study
was a time longer than or equal to 10.85 s in the performance
of the TUG test. This time was lower than the time that is
predictive of falls in elderly Brazilians (X12.47 s) (8). No
reference values for the TUG test exist for the prediction of
sarcopenia, according to the definitions of the consensus of
The EuropeanWorking Group on Sarcopenia in Older People
(5), which limits comparisons with reference values. One of
the reasons that the TUG test predicts sarcopenia with good
accuracy might be the significant muscular participation that
is required for transferring rapidly from a sitting position to a
standing position, which is one of the test activities.
Falsarella et al. (20) evaluated the influence of muscle and
bone mass on the functionality of 99 elderly women and
observed that reduced muscle mass was associated with
poor physical performance in the gait-speed and TUG tests.
In this study, reduced muscle mass (po0.01) was observed in
elderly patients with a poor physical performance (time
X10.85 s on the TUG test) in an intergroup comparison; this
finding suggests that the skeletal muscle mass variable might
be associated with performance on the TUG test. One reason
for this association might be the changes in muscle
composition during aging; these alterations might occur in
parallel with reduction in muscle strength and thereby affect
physical performance in this population.
The individuals with the worst physical performance
exhibited worse cognitive function. This finding suggests
that a relationship might exist between these variables. This
study had a cross-sectional design, and whether a causal
relationship exists between these variables could not be
determined; however, a recent study did not find an
association between sarcopenia and cognitive dysfunction
after adjusting for the confounding variables (21). Addition-
ally, high Charlson Comorbidity Index scores in elderly
subjects with poor physical performance suggest that a
greater presence of comorbidities might be associated with
changes in performance; changes in performance might
result from sarcopenia secondary to one or more comorbid-
ities, in addition to primary sarcopenia, which occurs with
aging (5).
Using sensitive tests to identify risk factors for patients is
crucial because such tests facilitate the identification of
patients who would benefit from physical therapy and
specific clinical interventions. This study demonstrated that
the TUG test might be capable of identifying patients with
and without sarcopenia because it had a sensitivity of 67%





Gender (male) 40 (58.8)




Comorbidity Index score 5.35±1.97
Mini-mental state examination score 23.7±5.0
Skeletal muscle mass (kg) 22.9±6.1
Muscle mass index (kg/m2) 8.65±1.92
Handgrip strength (kgf) 27.7±9.0
Timed Up and Go test time (s) 10.02±5.38
Falls in previous 12 months (yes) 21 (30.9)
Table 2 - Diagnostic performance of the Timed Up and Go test
for predicting sarcopenia in the sample of 68 elderly hospitalized
patients.
% 95% CI p-value
Sensitivity 66.7 0.38–0.85
Specificity 88.7 0.77–0.96
Accuracy 0.80 0.66–0.94 0.001
Figure 1 - Accuracy of the test Time Up and Go to predict
sarcopenia in the sample of 68 elderly hospitalized patients.
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and a specificity of 88.7%. The diagnosis of sarcopenia was
based in part on the estimated skeletal muscle mass, which
was computed using an anthropometric equation that
exhibited high sensitivity and specificity with the gold-
standard measurement techniques used in previous studies,
including a recent study in a Brazilian population (9,10).
In spite of this high correlation, anthropometry is consid-
ered to result in measurements that are less accurate than
those obtained using gold-standard measurement methods
(magnetic resonance imaging, computed tomography and
dual energy X-ray absorptiometry) (22). The feasibility of
using these more accurate instruments is restricted by
operational and financial aspects of daily clinical practice.
Another consideration is that the use of the SMM obtained
with the anthropometric equation, as with the use of the BMI,
is limited in that it does not distinguish among the different
components of body mass, such as muscle, bone and fat. This
limitation suggests that this instrument should not be used to
measure the responses to interventions over time. Although
the physical tests did not exhibit the level of accuracy of the
gold-standard methods, using these tests is more feasible in
daily practice, and their use might facilitate identification of
patients with sarcopenia among elderly hospitalized patients.
This factor is of extreme importance because the elderly
population is more vulnerable to complications (23,24),
particularly in the musculoskeletal system, and the conse-
quences, including falls or death, might be severe.
Another limitation is that the studied population included
only elderly patients who were able to walk without any
assistance; this limitation prevents use of the TUG test to predict
sarcopenia in elderly individuals who need assistive devices.
The Timed Up and Go test was shown to be a good
predictor of sarcopenia in elderly hospitalized patients.
Evaluating physical performance with this test might
provide another method for identifying elderly patients with
sarcopenia in cases in which a patient’s TUG test time is over
10.85 s. In this study, the patients with the worst physical
performance were older and had worse cognitive function
and less SMM.
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SMI (kg/m2) 9.1±1.7 7.3±2.0 0.001
MMSE score 24.8±3.9 20.3±6.6 0.002




MMSE: mini-mental state examination; TUG: Timed Up and Go; SMI:
skeletal muscle mass index.
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